German
biotechnology company Coriolis Pharma is the first tenant of the Spark Axis
Building in Morrisville.
Coriolis Pharma
CEO Silvia Steyrer-Gruber said the company would invest $10 million and create
50 jobs.
“We are very
thankful for the partners that we found in the county, in the town [and] in the
state to build this up,” Steyrer-Gruber said.
The Spark Axis
Building at 4921 McCrimmon Parkway in Morrisville will be Coriolis Pharma’s
first U.S. facility and its U.S. headquarters.
Founded in
Martinsried, Germany, Coriolis Pharma specializes in drug product development,
analytical and manufacturing services, supporting a wide range of biological
therapeutic modalities. Coriolis designs and executes platform-based and custom
solutions to accelerate and safeguard its clients’ programs from early
development through commercialization.
“For us, this
expansion is really more than just building up a new facility … because this is
a strategic step in our journey as a company,” Steyrer-Gruber said.
Coriolis Pharma
was founded in 2008.
“Your expertise
is at the forefront of bringing critical therapies and medicines to the world,”
town of Morrisville economic development director Tiffany McNeill said of
Coriolis Pharma. “We’re incredibly proud that you’ve chosen Morrisville for
this next pivotal step.”
Morrisville
Mayor T.J. Cawley echoed McNeill’s sentiments.
“This milestone
reflects years of strategic work to attract life sciences investment to our
town, including opening hundreds of acres to innovation and updating our
regulations to support companies developing life-changing and life-saving
treatments,” Cawley said.
